SUPERNEWS - NASDAQ:GILD (Gilead Sciences, Inc.) Stock Price, News, Quote, History

SUPERNEWS

Equities

Top Stories

Gold and Gold Stocks Shine, Outperform S&P 500 and Nasdaq

5/16, 13:48 EDT

Gold Rally Hits $2,308, Miners Gain 30%: Early Stages?

Gold prices hit a record $2,308.80 per ounce, driven by central bank purchases and anticipation of a Fed rate cut.

4/4, 12:43 EDT

Gold Gains 1.1%; RBC Bearings Shares Rise 16% After Q4 Results

Gold Prices Rise 1.1% to $2,411.70; RBC Bearings' Q4 Net Sales Up 4.9% to $413.7 Million

5/17, 12:39 EDT

Gold Soars to $2,345 Amid Central Banks' Record Buys

Gold hits record $2,345.40 an ounce amid central bank buying spree, rate cut expectations, and geopolitical tensions.

4/5, 16:09 EDT

Gold Hits Record $2,222; Eyes on $2,500 Amid Rate Cuts

Gold hits record $2,222.39/oz amid rate cut expectations and geopolitical tensions, with central banks and ETFs driving demand.

3/21, 19:40 EDT

Gold and Gold Stocks Shine, Outperform S&P 500 and Nasdaq

5/16, 13:48 EDT

Gold Rally Hits $2,308, Miners Gain 30%: Early Stages?

4/4, 12:43 EDT

Gold Gains 1.1%; RBC Bearings Shares Rise 16% After Q4 Results

5/17, 12:39 EDT

GILD News

Gold Gains 1.1%; RBC Bearings Shares Rise 16% After Q4 Results

5/17, 12:39 EDT

Gold and Gold Stocks Shine, Outperform S&P 500 and Nasdaq

5/16, 13:48 EDT

Gold Nears $2,356, Awaits US CPI for Fed Rate Clues

5/15, 03:39 EDT

Gold Prices Soar to $2,342 Amid Crisis, May Hit $3,200 by 2027

5/13, 08:34 EDT

Gold Hits $2,375 on Rate Cut Hopes, Soft U.S. Data

5/10, 20:50 EDT

Lazard Hires Colocci for Healthcare, Eyes Global Expansion

5/9, 05:03 EDT

Gold Hits Record, Einhorn Sees $3,500 Amid East's Rush

4/28, 21:58 EDT

Gold Hits $2330 Amid US Economic Woes, Fed Watch

4/26, 10:31 EDT

HubSpot, Wingstop Beat Forecasts; Meta Eyes Growth

4/26, 07:47 EDT

Gilead Q1 Loss Beats Forecasts, Cuts Year Guidance

4/26, 06:34 EDT

Earnings Surge with 3.5% Growth, Tech Leads Market Stability

4/25, 19:03 EDT

Analyst-Favored Stocks Offer Defense Amid Market Downturn

4/25, 11:25 EDT

Busy Earnings Week: Key Stocks May Face Declines

4/24, 09:18 EDT

GSK, Others Await Zantac Ruling Amid $45B Liability Concerns

4/24, 08:30 EDT

Dalio Backs Gold Amid $34T Debt, Spot Price Hits $2368.73

4/22, 03:03 EDT

Gold Soars to $2,440, Central Banks Drive Record Rally

4/12, 13:57 EDT

Gold Prices Soar, Stocks Set for Seasonal Surge Amid Fed Cuts

4/12, 06:32 EDT

Gold Soars to $2,395 Amid Mideast Tensions, Fed Cuts Hint

4/11, 23:16 EDT

Gold Nears Record Highs, Miners Eye $3,000/Oz Rally

4/10, 13:22 EDT

Gold Rally Predicted to Soar Amid Fed Cuts, Central Bank Buys

4/9, 23:36 EDT

Central Banks Boost Gold Holdings, Prices Soar to $2,345/Oz

4/7, 02:13 EDT

Dow Up 300 Points But Schiff Sees Gold Outshining Stocks

4/6, 04:02 EDT

Gold Prices Surge to Record High of $2,276/oz Amid Global Economic Uncertainties

4/5, 16:14 EDT

Gold Soars to $2,345 Amid Central Banks' Record Buys

4/5, 16:09 EDT

Gold Rally Hits $2,308, Miners Gain 30%: Early Stages?

4/4, 12:43 EDT

Einhorn Bets Big on Gold Amid Inflation, Eyes Value Stocks

4/3, 15:13 EDT

Gold Hits Record $2,308 Amid Economic Fears, FCX Soars

4/3, 12:54 EDT

Gold Soars to $2288, Silver Peaks Amid Rate Cut Buzz

4/3, 12:18 EDT

Gold Hits Record $2,308 Amid Rate Cut Hopes, Overextension Fears

4/3, 08:10 EDT

Gold Soars to $2,230, Eyes $2,250 Amid Rate Cut Hopes

4/2, 14:18 EDT

Wall Street Views

Evercore ISI

Steve Sakwa, 4/25/24

Bullish on

FSLR

GILD

“Few large cap REITs exhibit high single digit compound AFFO growth potential over the next 3 years and fewer still are inflecting to such extent.”

Banque Pictet & Cie

Hans Peter Portner, 3/26/24

Bullish on

GILD

NFLX

“We are ahead of a massive wave of new innovation in general, but in particular within biotech due to AI.”

Goldman Sachs

David Kostin, 3/25/24

Neutral on

DUK

GILD

“Both our expected path of the federal funds rate and our above-consensus economic growth forecast appear to already be priced by markets.”

BMO Capital Markets

Evan David Seigerman, 2/12/24

Bullish on

GILD

“The deal is 'a positive for Gilead shares,' as it deploys capital 'into de-risked assets in therapeutics areas the company knows well with opportunity for synergy.'”